Delivery Order SPE2DR25D3301-SPE2DR26F18JS
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of ENBREL 50 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order has a ceiling value of $224,446.26 and an ultimate completion date of September 26, 2025. The work will be performed at AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $46,557.92 by the Defense Logistics Agency (DLA) on September 16, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This competitive award, which carries no set-aside designation, is structured as a firm fixed price delivery order with an ultimate completion date of September 17, 2025. The contract will be performed at...
- AmerisourceBergen Drug Corp received a delivery order valued at $18,549.82 from the Defense Logistics Agency (DLA) on November 18, 2025, for the supply of ENBREL 50 mg/mL SureClick auto-injectors. This is a firm fixed price, non-competitive delivery order with a completion date of November 19, 2025, with performance to be executed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Enbrel 50 mg/ml SureClick auto-injector pharmaceutical product valued at $75,487.57 by the Defense Logistics Agency's Medical Supply Chain on September 23, 2025. This firm fixed price delivery order, with an ultimate completion date of September 24, 2025, represents a non-competitive, non-set-aside award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $33,974.03 by the Defense Logistics Agency (DLA) on August 5, 2025, with an ultimate completion date of August 6, 2025. The delivery order, awarded under firm fixed-price terms with no set-aside designation, calls for the supply of Enbrel 50 mg/mL syringes. This award represents a child contract executed under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $21,811.13 for ENBREL 50 MG/ML SureClick auto-injector medication. The contract, awarded on June 24, 2025, with an ultimate completion date of June 25, 2025, was competitively awarded with no set-aside designation. The delivery order is being funded by the Defense Logistics Agency's Medical Supply Chain division and will be performed...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,090.03 for ENBREL 50 mg/ml SureClick auto-injectors, with an ultimate completion date of April 25, 2025. This firm fixed price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The pharmaceutical will be...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $38,525.93 by the Defense Logistics Agency (DLA) on August 26, 2025, with an ultimate completion date of August 27, 2025. The contract covers the supply of Enbrel 50 mg/ml SureClick auto-injector units, a biologic medication used for treating rheumatoid arthritis and other inflammatory conditions. This competitive award to...
- The Defense Logistics Agency awarded a $29,943.60 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors, a biologic medication used to treat rheumatoid arthritis and other inflammatory conditions. This firm fixed-price, competitively awarded contract was issued on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) valued at $9,253.56 for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This firm fixed price, competitively awarded contract carries an ultimate completion date of August 11, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under a larger indefinite delivery contract vehicle and reflects the DLA's...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F18JSDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $146,463.86 by the Defense Logistics Agency on November 20, 2025, with an ultimate completion date of November 21, 2025. The contract, issued under firm fixed pricing with no set-aside designation, covers the supply of ENBREL 50 mg/ml SureClick auto-injectors, a biologic medication used to treat rheumatoid arthritis and other inflammatory conditions. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.999 billion ceiling value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. As a critical vendor in the federal medical supply chain, AmerisourceBergen Drug Corp fulfills pharmaceutical procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to meet stringent federal procurement standards through competitive procurement processes. This delivery order for ENBREL represents routine pharmaceutical replenishment under the broader SPE2DX framework, which enables flexible and efficient sourcing of specialty medications and medical supplies to support military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $146.5k | 11/20/25 |